Tag: DETOUR1

PQ Bypass Releases Positive 24-Month Data from the DETOUR1 Clinical Trial for Percutaneous Femoropopliteal Bypass at VIVA 2020

Promising long-term safety and effectiveness results from PAD population with extremely complex SFA disease MILPITAS, Calif.–(BUSINESS WIRE)–PQ Bypass, Inc, a medical device pioneer bringing new advancements to the treatment of complex peripheral artery disease (PAD), announces promising long-term safety and […]